• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[帕博利珠单抗给药后出现大疱性药物反应:两例病例报告]

[Bullous drug reaction after pembrolizumab administration: two case reports].

作者信息

Golle L, Michl C, Kreft B

机构信息

Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Deutschland.

出版信息

Dermatologie (Heidelb). 2022 Dec;73(12):959-964. doi: 10.1007/s00105-022-05018-0. Epub 2022 Jun 9.

DOI:10.1007/s00105-022-05018-0
PMID:35925211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9700574/
Abstract

Severe, blistering, adverse drug reactions involving the skin include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Allopurinol, anticonvulsants, sulphonamide antibiotics and non-steroidal anti-inflammatory drugs in the oxicam class have been repeatedly described as triggers. Increasingly, immunotherapies are also coming into focus as triggers of severe skin reactions. Two patients with bullous skin symptoms after administration of the checkpoint inhibitor pembrolizumab are presented. As the clinical picture does not always allow an unequivocal classification, a histological assessment is often indispensable.

摘要

涉及皮肤的严重水疱性药物不良反应包括史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)。别嘌醇、抗惊厥药、磺胺类抗生素以及恶丙嗪类非甾体抗炎药一再被描述为引发因素。越来越多的免疫疗法也成为严重皮肤反应的引发因素。本文介绍了两名在使用检查点抑制剂派姆单抗后出现大疱性皮肤症状的患者。由于临床表现并不总是能明确分类,组织学评估往往必不可少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ed/9700574/24e49e2ba064/105_2022_5018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ed/9700574/dacd2b5bee8a/105_2022_5018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ed/9700574/24e49e2ba064/105_2022_5018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ed/9700574/dacd2b5bee8a/105_2022_5018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ed/9700574/24e49e2ba064/105_2022_5018_Fig2_HTML.jpg

相似文献

1
[Bullous drug reaction after pembrolizumab administration: two case reports].[帕博利珠单抗给药后出现大疱性药物反应:两例病例报告]
Dermatologie (Heidelb). 2022 Dec;73(12):959-964. doi: 10.1007/s00105-022-05018-0. Epub 2022 Jun 9.
2
Stevens-Johnson syndrome and toxic epidermal necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症。
Chem Immunol Allergy. 2012;97:149-66. doi: 10.1159/000335627. Epub 2012 May 3.
3
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的最新观点。
Clin Rev Allergy Immunol. 2018 Feb;54(1):147-176. doi: 10.1007/s12016-017-8654-z.
4
Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.帕博利珠单抗诱发的转移性食管腺癌患者中毒性表皮坏死松解症
R I Med J (2013). 2022 Apr 1;105(3):34-36.
5
[Acute life-threatening drug reactions of the skin].[皮肤急性危及生命的药物反应]
Hautarzt. 2018 May;69(5):364-375. doi: 10.1007/s00105-018-4176-8.
6
Toxic epidermal necrolysis associated with pembrolizumab.与帕博利珠单抗相关的中毒性表皮坏死松解症。
J Oncol Pharm Pract. 2020 Jul;26(5):1259-1265. doi: 10.1177/1078155219890659. Epub 2019 Dec 6.
7
Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.意大利北部史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)的发病率、致病因素及死亡率:来自REACT注册研究的数据
Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):196-203. doi: 10.1002/pds.3937. Epub 2015 Dec 21.
8
[Severe drug-induced skin reactions. Stevens-Johnson syndrome and toxic epidermal necrolysis].[严重药物性皮肤反应。史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症]
Hautarzt. 2014 May;65(5):415-23. doi: 10.1007/s00105-013-2694-y.
9
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.对来自中国的213例史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症病例的回顾性研究。
Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30.
10
Levamisole induced toxic epidermal necrolysis: A case report.左旋咪唑诱导的中毒性表皮坏死松解症:一例报告。
Br J Clin Pharmacol. 2021 Mar;87(3):1574-1577. doi: 10.1111/bcp.14533. Epub 2020 Sep 9.

引用本文的文献

1
[Dermatological conditions requiring intensive care treatment].[需要重症监护治疗的皮肤病状况]
Dermatologie (Heidelb). 2025 May;76(5):314-326. doi: 10.1007/s00105-025-05497-x.
2
[Dermatological conditions requiring intensive care treatment].[需要重症监护治疗的皮肤病]
Med Klin Intensivmed Notfmed. 2025 Mar;120(2):170-182. doi: 10.1007/s00063-024-01239-4. Epub 2025 Feb 13.
3
Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.

本文引用的文献

1
Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症样反应的检查点抑制剂:系统评价。
Int J Dermatol. 2020 Jun;59(6):e183-e188. doi: 10.1111/ijd.14811. Epub 2020 Feb 13.
2
Toxic epidermal necrolysis associated with pembrolizumab.与帕博利珠单抗相关的中毒性表皮坏死松解症。
J Oncol Pharm Pract. 2020 Jul;26(5):1259-1265. doi: 10.1177/1078155219890659. Epub 2019 Dec 6.
3
Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Metastatic Cervical Squamous Cell Carcinoma: A Case Report.
免疫检查点抑制剂诱导的表皮坏死松解症:评估人口统计学、临床特征和罪魁祸首药物的叙述性综述。
J Dermatol. 2024 Jan;51(1):3-11. doi: 10.1111/1346-8138.17039. Epub 2023 Nov 30.
帕博利珠单抗致转移性宫颈鳞癌患者史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症 1 例报告
Am J Dermatopathol. 2020 Apr;42(4):292-296. doi: 10.1097/DAD.0000000000001527.
4
[Not Available].[无可用内容]。
J Dtsch Dermatol Ges. 2019 Sep;17(9):943-949. doi: 10.1111/ddg.13876_g.
5
Treatment Outcomes of Immune-Related Cutaneous Adverse Events.免疫相关性皮肤不良反应的治疗结果。
J Clin Oncol. 2019 Oct 20;37(30):2746-2758. doi: 10.1200/JCO.18.02141. Epub 2019 Jun 19.
6
Pembrolizumab induced toxic epidermal necrolysis.帕博利珠单抗诱发中毒性表皮坏死松解症。
Curr Probl Cancer. 2020 Apr;44(2):100478. doi: 10.1016/j.currproblcancer.2019.05.001. Epub 2019 May 14.
7
Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system.PD-1 抑制剂不良事件报告系统中与 PD-1 抑制剂相关的大疱性类天疱疮不良事件的比例分析。
Expert Opin Drug Saf. 2019 Jul;18(7):623-633. doi: 10.1080/14740338.2019.1619693. Epub 2019 May 22.
8
Atezolizumab-Induced Stevens-Johnson Syndrome in a Patient with Non-Small Cell Lung Carcinoma.阿替利珠单抗诱发非小细胞肺癌患者发生史蒂文斯-约翰逊综合征
Case Rep Dermatol. 2018 Aug 9;10(2):198-202. doi: 10.1159/000492172. eCollection 2018 May-Aug.
9
Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.帕博利珠单抗诱发肺癌患者发生史蒂文斯-约翰逊综合征
J Thorac Oncol. 2018 Nov;13(11):1798-1799. doi: 10.1016/j.jtho.2018.05.031. Epub 2018 Jun 6.
10
Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma.与使用纳武单抗(一种PD-1抑制剂)治疗淋巴瘤相关的中毒性表皮坏死松解症(TEN)
JAAD Case Rep. 2018 Feb 23;4(3):229-231. doi: 10.1016/j.jdcr.2017.09.028. eCollection 2018 Apr.